{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:54:15Z","timestamp":1790553255435,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T00:00:00Z","timestamp":1577750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703149"],"award-info":[{"award-number":["81703149"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81502709"],"award-info":[{"award-number":["81502709"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602784"],"award-info":[{"award-number":["81602784"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.intimp.2019.106178","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T23:50:10Z","timestamp":1578354610000},"page":"106178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Hydroxychloroquine is a novel therapeutic approach for rosacea"],"prefix":"10.1016","volume":"79","author":[{"given":"Ji","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhili","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2019.106178_b0005","article-title":"An observational descriptive survey of rosacea in the Chinese population: clinical features based on the affected locations","volume":"7","author":"Xie","year":"2017","journal-title":"Peer J."},{"issue":"1","key":"10.1016\/j.intimp.2019.106178_b0010","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jaad.2017.07.055","article-title":"Evidence-based update on rosacea comorbidities and their common physiologic pathways","volume":"78","author":"Holmes","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.intimp.2019.106178_b0015","doi-asserted-by":"crossref","DOI":"10.1080\/19381980.2017.1361574","article-title":"Rosacea: epidemiology, pathogenesis, and treatment","volume":"9","author":"Rainer","year":"2017","journal-title":"Dermatoendocrinol."},{"issue":"3","key":"10.1016\/j.intimp.2019.106178_b0020","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2017.09.004","article-title":"Frontal fibrosing alopecia and cutaneous comorbidities: a potential relationship with rosacea","volume":"78","author":"Pindado-Ortega","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.intimp.2019.106178_b0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/1346-8138.14771","article-title":"Relationship between rosacea and dietary factors: a multicenter retrospective case-control survey","volume":"46","author":"Yuan","year":"2019","journal-title":"J. Dermatol."},{"issue":"2","key":"10.1016\/j.intimp.2019.106178_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192487","article-title":"The Rosacea-specific Quality-of-Life instrument (RosQol): revision and validation among Chinese patients","volume":"13","author":"Deng","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2019.106178_b0035","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.intimp.2018.12.031","article-title":"Tranexamic acid ameliorates rosacea symptoms through regulating immune response and angiogenesis","volume":"67","author":"Li","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2019.106178_b0040","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm1616","article-title":"Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea","volume":"13","author":"Yamasaki","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2019.106178_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109181","article-title":"Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea","volume":"117","author":"Yuan","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.intimp.2019.106178_b0050","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2567.2010.03395.x","article-title":"Catestatin, a neuroendocrine antimicrobial peptide, induces human mast cell migration, degranulation and production of cytokines and chemokines","volume":"132","author":"Aung","year":"2011","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.intimp.2019.106178_b0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.trsl.2009.03.006","article-title":"Stimulation of CCL2 (MCP-1) and CCL2 mRNA by substance P in LAD2 human mast cells","volume":"154","author":"Castellani","year":"2009","journal-title":"Transl. Res."},{"issue":"11","key":"10.1016\/j.intimp.2019.106178_b0060","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1038\/jid.2014.222","article-title":"Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea","volume":"134","author":"Muto","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"11","key":"10.1016\/j.intimp.2019.106178_b0065","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4049\/jimmunol.1100123","article-title":"Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis","volume":"187","author":"Lin","year":"2011","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2019.106178_b0070","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/exd.13381","article-title":"Inhibition of mast cell infiltration in an LL-37-induced rosacea mouse model using topical brimonidine tartrate 0.33% gel","volume":"26","author":"Kim","year":"2017","journal-title":"Exp. Dermatol."},{"issue":"4","key":"10.1016\/j.intimp.2019.106178_b0075","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jid.2016.10.046","article-title":"TRPV4 mediates mast cell activation in cathelicidin-induced Rosacea Inflammation","volume":"137","author":"Mascarenhas","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.intimp.2019.106178_b0080","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/archdermatol.2011.2558","article-title":"Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: a French multicenter prospective study","volume":"148","author":"Franc\u00e8s","year":"2012","journal-title":"Arch. Dermatol."},{"issue":"11","key":"10.1016\/j.intimp.2019.106178_b0085","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/art.22159","article-title":"Hydroxychloroquine in lupus pregnancy","volume":"54","author":"Clowse","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.intimp.2019.106178_b0090","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.autrev.2004.11.009","article-title":"Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature","volume":"4","author":"Costedoat-Chalumeau","year":"2005","journal-title":"Autoimmun. Rev."},{"issue":"7","key":"10.1016\/j.intimp.2019.106178_b0095","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.autrev.2018.01.016","article-title":"New use for an old treatment: hydroxychloroquine as a potential treatment for systemic vasculitis","volume":"17","author":"Casian","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2019.106178_b0100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/rheumatology\/kex378","article-title":"The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies","volume":"57","author":"Schreiber","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2019.106178_b0105","doi-asserted-by":"crossref","unstructured":"T. Fan, H. Pi, M. Li, Z. Ren, Z. He, F. Zhu, L. Tian, M. Tu, J. Xie, M. Liu, Y. Li, M. Tan, W. Li GQing, R.J. Reiter, Z. Yu, H. Wu, Z. Zhou, Inhibiting MT2-TFE3-dependent autophagy enhances melatonin-induced apoptosis in tongue squamous cell carcinoma, J. Pineal Res. 64 (2) (2018) e12457.","DOI":"10.1111\/jpi.12457"},{"issue":"Suppl 1","key":"10.1016\/j.intimp.2019.106178_b0110","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1177\/0961203396005001031","article-title":"Anti-malarial drugs: possible mechanisms of action in autoimmune disease and prospects for drug development","volume":"5","author":"Fox","year":"1996","journal-title":"Lupus"},{"issue":"18","key":"10.1016\/j.intimp.2019.106178_b0115","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.clim.2018.07.004","article-title":"Hydroxychloroquine as a novel therapeutic approach in mast cell activation diseases","volume":"194","author":"Espinosa","year":"2018","journal-title":"Clin. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2019.106178_b0120","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1158\/1078-0432.CCR-18-2204","article-title":"Autophagy Inhibition to Augment mTOR Inhibition: a Phase I\/II trial of everolimus and hydroxychloroquine in patients with previously treated renal cell carcinoma","volume":"25","author":"Haas","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.intimp.2019.106178_b0125","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-212668","article-title":"Cardiovascular effects of hydroxychloroquine: a systematic review and meta-analysis","volume":"77","author":"Mathieu","year":"2018","journal-title":"Ann Rheum Dis."},{"issue":"5","key":"10.1016\/j.intimp.2019.106178_b0130","first-page":"1124","article-title":"The influence of antimalarial treatment on IL-1beta, IL-6 and TNF-alpha mRNA expression on UVB-irradiated skin in systemic lupus erythematosus","volume":"159","author":"Wozniacka","year":"2008","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.intimp.2019.106178_b0135","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1046\/j.1523-1747.2003.12613.x","article-title":"Generation of a large number of connective tissue type mast cells by culture of murine fetal skin cells","volume":"121","author":"Yamada","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2019.106178_b0140","doi-asserted-by":"crossref","unstructured":"M. Schaller, L. Kemeny, B. Havlickova, J.M. Jackson, M. Ambroziak, C. Lynde, M. Gooderham, E. Remenyik, J. Del Rosso, J. Weglowska, R. Chavda, T. Kerrouche NDirschka, S. Johnson, Arandomizedphase3b\/4studyto evaluateconcomitant use of topical ivermectin 1% cream and doxycycline 40 mg modified-release capsules versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea, J. Am. Acad. Dermatol.28 (19) (2019)pii: S0190-9622(19)30867-9.","DOI":"10.1016\/j.jaad.2019.05.063"},{"issue":"43","key":"10.1016\/j.intimp.2019.106178_b0145","doi-asserted-by":"crossref","first-page":"37358","DOI":"10.1074\/jbc.M111.272401","article-title":"Dual targets for mouse mast cell protease-4 in mediating tissue damage in experimental bullous pemphigoid","volume":"286","author":"Lin","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2019.106178_b0150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00403-007-0816-z","article-title":"A study of the pathogenesis of rosacea: how angiogenesis and mast cells may participate in a complex multifactorial process","volume":"300","author":"Aroni","year":"2008","journal-title":"Arch. Dermatol. Res."},{"issue":"2","key":"10.1016\/j.intimp.2019.106178_b0155","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cellimm.2014.12.006","article-title":"Human-derived cathelicidin LL-37 directly activates mast cells to proinflammatory mediator synthesis and migratory response","volume":"293","author":"Babolewska","year":"2015","journal-title":"Cell. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2019.106178_b0160","doi-asserted-by":"crossref","first-page":"8040","DOI":"10.4049\/jimmunol.180.12.8040","article-title":"Blunted IgE-mediated activation of mast cells in mice lacking the Ca2+-activated K+ channel KCa3.1","volume":"180","author":"Shumilina","year":"2008","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2019.106178_b0165","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1189\/jlb.0212091","article-title":"Molecular mechanisms of spontaneous and directed mast cell motility","volume":"92","author":"Lee","year":"2012","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2019.106178_b0170","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jdermsci.2018.12.004","article-title":"Botulinum toxin blocks mast cells and prevents rosacea like inflammation","volume":"93","author":"Choi","year":"2019","journal-title":"J. Dermatol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2019.106178_b0175","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jdermsci.2006.03.001","article-title":"Human cathelicidin LL-37 increases vascular permeability in the skin via mast cell activation, and phosphorylates MAP kinases p38 and ERK in mast cells","volume":"43","author":"Chen","year":"2006","journal-title":"J. Dermatol Sci."},{"issue":"11","key":"10.1016\/j.intimp.2019.106178_b0180","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1182\/blood.V95.11.3460","article-title":"Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunemodulatory properties","volume":"95","author":"Goldman","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2019.106178_b0185","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-01836-8","article-title":"Pro-inflammatory Ca(++)-activated K(+) channels are inhibited by hydroxychloroquine","volume":"7","author":"Eugenia Schroeder","year":"2017","journal-title":"Sci. Rep."},{"issue":"7542","key":"10.1016\/j.intimp.2019.106178_b0190","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919327614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919327614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:53:43Z","timestamp":1778619223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919327614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":38,"alternative-id":["S1567576919327614"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.106178","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydroxychloroquine is a novel therapeutic approach for rosacea","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.106178","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106178"}}